10,000 results · 392ms · Sources: EU EUDAMED, US FDA

Drexco Medical speculum vaginal cusco

Device
EU MDD · Eu Md Class 1 ·G P S S.R.L. ·On the market·2 countries

drexco medical

Device
EU MDD · Eu Md Class 1 ·G P S S.R.L. ·On the market·2 countries

Vis Activ Neo

Device
EU MDD · Eu Md Class 2b ·OPKO HEALTH SPAIN S.L.U.·On the market·1 country

drexo medical

Device
EU MDD · Eu Md Class 1 ·G P S S.R.L. ·On the market·2 countries

URIMED B'BAGS

Device
EU MDD · Eu Md Class 1 ·Tecnoclínic SA·On the market

TECNOCLINIC MEDICAL PRODUCTS

Device
EU MDD · Eu Md Class 1 ·Tecnoclínic SA·On the market

TECNOCLINIC MEDICAL PRODUCTS

Device
EU MDD · Eu Md Class 1 ·Tecnoclínic SA·On the market

TECNOCLINIC MEDICAL PRODUCTS

Device
EU MDD · Eu Md Class 1 ·Tecnoclínic SA·On the market

TECNOCLINIC MEDICAL PRODUCTS

Device
EU MDD · Eu Md Class 1 ·Tecnoclínic SA·On the market

TECNOCLINIC MEDICAL PRODUCTS

Device
EU MDD · Eu Md Class 1 ·Tecnoclínic SA·On the market

TECNOCLINIC MEDICAL PRODUCTS

Device
EU MDD · Eu Md Class 1 ·Tecnoclínic SA·On the market

TECNOCLINIC MEDICAL PRODUCTS

Device
EU MDD · Eu Md Class 1 ·Tecnoclínic SA·On the market

Cyclosporine

FDA Pre-Market Approval
FDA Class 2 ·EMIT 2000 CYCLOSPORINE SPECIFIC ASSAY

Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions

FDA Pre-Market Approval
FDA Class 3 ·DIMENSION FPSA FLEX REAGENT CARTRIDGE

Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions

FDA Pre-Market Approval
FDA Class 3 ·Dimension Vista FPSA Flex reagent cartridge (K6452)

Kit, Assay, Progesterone Receptor

FDA Pre-Market Approval
FDA Class 3 ·RIANEN(TM) (3H) PROGESTIN RECEPTOR ASSAY KIT

Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions

FDA Pre-Market Approval
FDA Class 3 ·Dimension FPSA Flex Reagent Cartridge

Lens, Contact (Polymethylmethacrylate)

FDA Pre-Market Approval
FDA Unclassified ·PARAPERM O2 CONTACT LENS CLEAR & BLUE

Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

FDA Pre-Market Approval
FDA Class 2 ·Dimension TPSA Flex reagent cartridge (RF451)

Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions

FDA Pre-Market Approval
FDA Class 3 ·DIMENSION FPSA FLEX REAGENT CARTRIDGE AND DIMENSION VISTA FPSA FLEX REAGENT CARTRIDGE